Preclinical Studies

A University of Virginia scientist has won the Hartwell Individual Biomedical Research Award for her work on neurodevelopmental disorders that occur during childhood. The research of Sanchita Bhatnagar, PhD, will be funded with $100,000 per year for three years. Bhatnagar is one of 12 recipients from 10 institutions to receive the award given by The Hartwell Foundation. Bhatnagar’s lab […]

by

TORONTO–(BUSINESS WIRE)–Oct 31, 2018–FSD Pharma Inc. (“ FSD Pharma ” or “ FSD ”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) today announced the launch of a pilot clinical study in Pittsburgh, Pennsylvania, by its strategic RD partner, SciCann Therapeutics (“ SciCann ”). The study is designed to test the safety and efficacy of SciCann’s proprietary […]

by

The two primary active components in marijuana are the psychoactive chemical delta9-tetrahydrocannabinol (THC), and the nonpsychoactive cannabidiol (CBD). Previous analytical methods were mostly developed to measure biomarkers of marijuana in users themselves. In this study, a new and more sensitive analytic method was developed and used by the US Centers for Disease Control and Prevention […]

by

Research published today reveals the existence of previously unknown signaling platforms which are responsible for the drug’s success in shrinking tumours. It is hoped that the findings could help develop a synthetic equivalent with anti-cancer properties. The research was co-led with the Universidad Complutense de Madridin, Spain. The team used samples of human breast cancer […]

by

Swallowing. It’s such a simple thing to do! We’re born with the ability to swallow; it happens automatically, and the average person does it approximately 600 times a day. I mean, who actually thinks about swallowing? Well, I do, now that I’ve joined the nearly 80 percent of ALS patients who have to think about […]

by

That is the question. Vitamin B, that is. And any other nutritional supplement. Shortly after ALS crashed my party, I was introduced to the book “Eric Is Winning,” by Eric Edney. Edney was a long-term ALS survivor (over 20 years) who attributed his longevity to a regimen that included, among other factors, nutritional supplements. The […]

by

Restoring or artificially raising levels of a protein found in the spinal cord, mitofusin 2,  worked to prevent nerve degeneration, muscle atrophy, and paralysis in a mouse model of amyotrophic lateral sclerosis, researchers report. As this protein is often depleted in ALS patients — and drops with aging — they believe that supplementing it offers […]

by

Patients with fragile X syndrome have faster protein synthesis and increased protein levels than healthy people, according to a recent study. These findings suggest that protein synthesis alterations could be an important biomarker of the disease and play an important role in its development. The study, “Protein synthesis levels are increased in a subset of […]

by

Canadian researchers are testing mice to see if cannabinoid oil products — a common medical marijuana treatment — could help alleviate the neuropathic pain that often afflicts patients with multiple sclerosis (MS). The preclinical study, “Identifying the molecular mechanisms involved in supressing multiple sclerosis induced neuropathic pain following cannabinoid treatment in an animal model of multiple sclerosis (MS),” […]

by

Live 2018 The Government of Quebec has awarded a total of  $500,000 in funding to McGill University and the Research Institute of the McGill University Health Centre (RI-MUHC). The funding will go to support the completion of two international research and innovation projects, which were selected at the end of the call for projects launched […]

by

Dravet syndrome is a serious form of childhood epilepsy that first shows up in babies at six to nine months old, resulting in cognitive impairments, autistic-like behaviors, and premature death.  About 15 percent of children with Dravet syndrome die before they reach the age of 13, according to William Catterall, a lead researcher, professor, and […]

by

The largest CBD study presented efficacy and safety data on GW Pharmaceutical’s investigational medicine, Epidiolex (cannabidiol) from open-label Expanded Access programs at 16 sites. The study (abstract 3.034) involves 261 people, predominantly children, who have severe epilepsy that had not responded adequately to other treatments. The average age of the participants was 11. Over the […]

by

Other research has shown that long-term use of cannabis increases adolescent drug users’ risk for certain psychiatric and neurological disorders, such as schizophrenia. The risk to teens is greater than ever since selective breeding of plants to produce higher levels of THC over the past several decades has substantially increased exposure to the compound. “This […]

by